Afghanistan currently reports a pregnant women living with hiv antiretroviral therapy coverage for pmtct of 15%, a decrease of 4% (-21.1%) from 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Afghanistan
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,975
Measure:
%
Similar regions to Afghanistan
More indicators for Afghanistan
Male unintentional poisoning
2.9
-0.4
(2021)
Female wasting in children
3.5%
-0.6%
(2022)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar299
+intl dollar20
(2022)
Birth registration
42.3%
+4.9%
(2015)
Contraceptive modern method prevalence
19.8%
+6%
(2015)
Afghanistan PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | Value | Change |
|---|---|---|
| 2022 | 15% | -4% |
| 2021 | 19% | +6% |
| 2020 | 13% | +1% |
| 2019 | 12% | +3% |
| 2018 | 9% | 0% |
| 2017 | 9% | +5% |
| 2016 | 4% | +1% |
| 2015 | 3% | -1% |
| 2014 | 4% | +2% |
| 2013 | 2% | +2% |
| 2012 | 0% | -1% |
| 2011 | 1% | 0% |
| 2010 | 1% | 0% |
| 2009 | 1% | +1% |
| 2008 | 0% | 0% |
| 2007 | 0% | 0% |
| 2006 | 0% | 0% |
| 2005 | 0% | 0% |
| 2004 | 0% | 0% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |